Wondering how to keep your appointment book full? Discover how marketing can help your practice.
Welcome to ModernMedicine
Drugs and devices in the pipeline from Bayer Healthcare, AVEO Oncology, Astellas Pharma Inc., Trimel Pharmaceuticals Corp., OncoGenex Pharmaceuticals, Inc., Nymox Pharmaceutical Corp., Spectrum Pharmaceuticals, and Tengion, Inc.
The tax laws have changed once again. Find out how they're going to affect you.
Advanced age does not influence postoperative continence or cancer-specific survival after radical prostatectomy, according to a recent study.
To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
The incidence of secondary malignancies following prostate cancer therapy is similarly uncommon whether the treatment is surgery, brachytherapy, or external beam therapy.
Recent analyses of urodynamic testing data indicate that both autologous fascial pubovaginal sling and synthetic midurethral sling procedures decrease maximum flow rate and increase bladder outlet resistance, but the pubovaginal sling was found to create more bladder outlet resistance.
For women with uncomplicated, stress-predominant incontinence, urodynamic testing adds considerable expense without improving surgical outcomes, a recent trial shows.
Urologists share how confident they feel about active surveillance for low-risk prostate cancer.
Preoperative urodynamic testing in women undergoing surgery for uncomplicated, stress-predominant urinary incontinence commonly results in a change in clinical diagnosis.